Nadia Stec, MSc

Nadia is a contributing freelance journalist at Xtalks. She completed her MSc in Biology at the University of Ottawa and a BSc in Life Sciences at the University of Toronto, and since then has worked as a writer in different fields and published peer-reviewed papers. She enjoys researching new scientific topics and making technical information more accessible.

Sunlenca (lenacapavir) Receives FDA Approval as HIV Treatment Option for Multi-Drug Resistant Infection
Sunlenca (lenacapavir) Receives FDA Approval as HIV Treatment Option for Multi-Drug Resistant Infection
News

Vraylar (cariprazine) Approved as Adjunctive Treatment for Major Depressive Disorder
Vraylar (cariprazine)
Life Science News

Iyuzeh Approved for Reduction of Elevated Intraocular Pressure for Patients with Open-Angle Glaucoma or Ocular Hypertension
Iyuzeh
News

Dexcom G7 Continuous Glucose Monitor Cleared by FDA for All Types of Diabetes
Dexcom G7
News

Quantra Hemostasis System by HemoSonics Gets FDA 510(k) Clearance
Quantra Hemostasis System by HemoSonics Gets FDA 510(k) Clearance
News

European Commission Approves Skyrizi (risankizumab) for the Treatment of Crohn’s Disease
Skyrizi (risankizumab)
News

Rinvoq Gets FDA Approval for Treatment of Non-Radiographic Axial Spondyloarthritis
Non-Radiographic Axial Spondyloarthritis
Pharma News

Boostrix Gains FDA Approval as Prenatal Immunization to Prevent Whooping Cough in Newborns
Boostrix
News

Omlonti Granted FDA Approval in Glaucoma and Ocular Hypertension
Omlonti eye drops for reducing elevated intraocular pressure (IOP) in patients with primary open-angle glaucoma or ocular hypertension.
News

Relyvrio Approved as ALS Treatment by the FDA
Relyvrio
News

Spevigo Becomes First Treatment Option for Generalized Pustular Psoriasis Flares
Boehringer Ingelheim’s Spevigo (spesolimab-sbzo) was FDA-approved as the first treatment option for generalized pustular psoriasis (GPP) flares in adults.
News

Daxxify, a New Anti-Wrinkle Drug and Botox Competitor is FDA-Approved
Daxxify
News